Login / Signup

Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance?

L GazzolaGianmarco TagliaferriA De BonaD MondatoreC BorsinoT BiniGiulia Carla MarchettiAntonella d'Arminio Monforte
Published in: HIV medicine (2020)
Switching from TDF to TAF affects lipid parameters, and data from real life suggest a clinical relevance of this worsening that often leads clinicians to implement lifestyle/therapeutic interventions.
Keyphrases